{
    "id": "0251",
    "question": "A 71-year-old man complains of urinary hesitancy and nocturia of increasing frequency over the past several months. Digital rectal exam was positive for a slightly enlarged prostate but did not detect any additional abnormalities of the prostate or rectum. The patient\u2019s serum PSA was measured to be 6 ng/mL. Image A shows a transabdominal ultrasound of the patient. Which of the following medications should be included to optimally treat the patient's condition?",
    "options": {
        "A": "Clonidine",
        "B": "Finasteride",
        "C": "Dihydrotestosterone",
        "D": "Furosemide"
    },
    "answer": "B",
    "predict": "To determine the most suitable medication for this patient, let's break down the information provided: 1. **Patient's symptoms**: Urinary hesitancy and nocturia (frequent urination at night) are common symptoms of Benign Prostatic Hyperplasia (BPH), a non-cancerous enlargement of the prostate gland. The patient's age (71 years) also increases the likelihood of BPH. 2. **Digital rectal exam findings**: The examination revealed a slightly enlarged prostate, which further supports the diagnosis of BPH. 3. **PSA level**: The serum Prostate-Specific Antigen (PSA) level of 6 ng/mL is within the normal range (typically < 4 ng/mL). Elevated PSA levels are often associated with prostate cancer, but a normal PSA level does not rule out BPH. 4. **Ultrasound findings**: Although the ultrasound results are not explicitly described, the fact that an ultrasound was performed suggests that the clinician suspects BPH or other abnormalities of the prostate or rectum. Considering the patient's symptoms and examination findings, the primary goal is to alleviate urinary symptoms associated with BPH. Now, let's evaluate the medication options: - **A. Clonidine**: Primarily used to treat high blood pressure and ADHD. It's not a standard treatment for BPH. - **B. Finasteride**: A 5-alpha-reductase inhibitor that reduces prostate size by blocking the conversion of testosterone to dihydrotestosterone (DHT), a hormone contributing to prostate growth. Finasteride is a common treatment for BPH. - **C. Dihydrotestosterone (DHT)**: This is the active metabolite of testosterone that contributes to prostate growth. Administering DHT would not be therapeutic in this context. - **D. Furosemide**: A diuretic used to treat fluid build-up (edema) and high blood pressure. It's not a standard treatment for BPH. Given the patient's symptoms and diagnosis of BPH, the most suitable medication to optimally treat the patient's condition is **B. Finasteride**, as it directly addresses the underlying cause of BPH by reducing DHT levels, thereby shrinking the prostate and alleviating symptoms. **{\"step_by_step_thinking\": \"The patient's symptoms and examination findings are consistent with Benign Prostatic Hyperplasia (BPH). Finasteride is a 5-alpha-reductase inhibitor that reduces prostate size and alleviates symptoms associated with BPH, making it the most suitable medication for this patient.\", \"answer_choice\": \"B\"}**",
    "snippets": [],
    "scores": [],
    "execution_time": 24.293646335601807
}